Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
Research and applications across a range of disease areas to improve allocative efficiency (the maximisation of health outcomes using the most cost-effective mix of interventions and implementation methods).
Optima models have been used extensively to address investment choices related to numerous areas including HIV/AIDS, tuberculosis, malaria, viral hepatitis, and nutrition.
Modelling groups affiliated with the Optima Consortium are continuing to extend the Optima approach, by developing new applications to inform investment of publicly-funded benefits packages for entire health systems, and for optimising implementation options across diverse sectors.
PAST PUBLICATIONS
World Bank, The Global Fund, The U.S. Centers for Disease Control, NHMRC.
For any general enquiries relating to this project, please contact:
Head of Infectious Disease Modelling; Co-Head, Strategy Insights and Impact
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
